US equities
|
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
NVDA
$217.94
▲+0.90%
TSLA
$407.46
▲+4.04%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
META
$620.19
▼-1.64%
MU
$928.76
▲+2.77%
NVDA
$217.94
▲+0.90%
TSLA
$407.46
▲+4.04%
SPCX
$148.58
▲+1.14%
AAPL
$347.10
▲+0.93%
AMD
$560.26
▲+5.45%
MSFT
$531.33
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Heartflow, Inc. - Common Stock
(NQ:
HTFL
)
57.82
+0.81 (+1.42%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Heartflow, Inc. - Common Stock
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
October 19, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
August 28, 2026
FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty,...
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
August 27, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
August 13, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026
July 23, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management
July 09, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
May 14, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
May 13, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026
April 23, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
April 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
USA News Group
Via
GlobeNewswire
Heartflow Files Patent Infringement Lawsuit Against Cleerly
April 13, 2026
Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
March 16, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
February 18, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
February 13, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes
February 12, 2026
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis
From
Heartflow, Inc.
Via
GlobeNewswire
AI Diagnostics: The End of the High-Cost Imaging Era
January 16, 2026
Issued on behalf of VentriPoint Diagnostics Ltd.
From
Equity Insider
Via
GlobeNewswire
Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.
January 06, 2026
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
December 18, 2025
Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease
December 11, 2025
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 19, 2025
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow Reports Third Quarter 2025 Financial Results
November 12, 2025
Initiates Full Year 2025 Revenue Guidance of $173.0 Million to $173.5 Million
From
Heartflow, Inc.
Via
GlobeNewswire
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
November 09, 2025
Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular events
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
November 03, 2025
Data to highlight the precision of AI-powered Heartflow Plaque Staging framework in predicting long-term cardiovascular outcomes
From
Heartflow, Inc.
Via
GlobeNewswire
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025
October 23, 2025
From
Heartflow, Inc.
Via
GlobeNewswire
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning
October 22, 2025
From
Heartflow, Inc.
Via
GlobeNewswire
